Foghorn Therapeutics Inc. (FHTX) Free cash flow 2019–2025
Foghorn Therapeutics Inc. (FHTX) annual free cash flow history — operating cash flow minus capital expenditures, per SEC filings.
-$86.1MFY2025 · since FY2019: -$47.3M → -$86.1M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$86.1M | +15.0% |
| FY2024 | -$101.3M | +15.1% |
| FY2023 | -$119.3M | -162.0% |
| FY2022 | $192.4M | +459.2% |
| FY2021 | -$53.6M | -12.8% |
| FY2020 | -$47.5M | -0.4% |
| FY2019 | -$47.3M | — |
Free cash flow = reported operating cash flow − reported capital expenditures for the same fiscal year.
Source: SEC XBRL filings · For reference only · Not investment advice